Whitehouse Laboratories, a division of Albany Molecular Research, said today that it has expanded its drug delivery device testing capabilities to include services for ISO 80369 standards.
The 8 standards described in ISO 80369 were designed to prevent connector errors in medical device and drug delivery systems. Whitehouse Labs said that the group’s latest expansion helps to position itself as one of the only places in the U.S. to offer compliance testing services for these standards.
Get the full story at our sister site, Drug Delivery Business News.
The post Whitehouse Labs expands drug delivery device testing capabilities appeared first on MassDevice.